# OnCo record anti-egfr-left-sided (pairing). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/pairings/anti-egfr-left-sided/>
  a schema:MedicalTherapy ;
  onco:kind "pairing" ;
  schema:identifier "anti-egfr-left-sided" ;
  schema:name "Anti-EGFR antibody + chemotherapy in left-sided RAS/BRAF wild-type mCRC"@en ;
  schema:description "In bowel cancers that start on the left and have normal RAS and BRAF genes, adding an EGFR antibody to chemotherapy gives the longest survival seen in first-line trials."@en ;
  schema:url <https://onco.cc/pairings/anti-egfr-left-sided/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02394795> ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/folfiri/> ;
  onco:terms <https://onco.cc/terms/sidedness/> ;
  onco:trials <https://onco.cc/trials/paradigm/>, <https://onco.cc/trials/crystal-fire3/> ;
  onco:pairs <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/folfox/> .